Rasch analysis of the Multiple Sclerosis Impact Scale (MSIS-29)

<p>Abstract</p> <p>Background</p> <p>Multiple Sclerosis (MS) is a degenerative neurological disease that causes impairments, including spasticity, pain, fatigue, and bladder dysfunction, which negatively impact on quality of life. The Multiple Sclerosis Impact Scale (MS...

Full description

Bibliographic Details
Main Authors: Misajon Rose, Khan Fary, Ramp Melina, Pallant Julie F
Format: Article
Language:English
Published: BMC 2009-06-01
Series:Health and Quality of Life Outcomes
Online Access:http://www.hqlo.com/content/7/1/58
_version_ 1830447791121367040
author Misajon Rose
Khan Fary
Ramp Melina
Pallant Julie F
author_facet Misajon Rose
Khan Fary
Ramp Melina
Pallant Julie F
author_sort Misajon Rose
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>Multiple Sclerosis (MS) is a degenerative neurological disease that causes impairments, including spasticity, pain, fatigue, and bladder dysfunction, which negatively impact on quality of life. The Multiple Sclerosis Impact Scale (MSIS-29) is a disease-specific health-related quality of life (HRQoL) instrument, developed using the patient's perspective on disease impact. It consists of two subscales assessing the physical (MSIS-29-PHYS) and psychological (MSIS-29-PSYCH) impact of MS. Although previous studies have found support for the psychometric properties of the MSIS-29 using traditional methods of scale evaluation, the scale has not been subjected to a detailed Rasch analysis. Therefore, the objective of this study was to use Rasch analysis to assess the internal validity of the scale, and its response format, item fit, targeting, internal consistency and dimensionality.</p> <p>Methods</p> <p>Ninety-two persons with definite MS residing in the community were recruited from a tertiary hospital database. Patients completed the MSIS-29 as part of a larger study. Rasch analysis was undertaken to assess the psychometric properties of the MSIS-29.</p> <p>Results</p> <p>Rasch analysis showed overall support for the psychometric properties of the two MSIS-29 subscales, however it was necessary to reduce the response format of the MSIS-29-PHYS to a 3-point response scale. Both subscales were unidimensional, had good internal consistency, and were free from item bias for sex and age. Dimensionality testing indicated it was not appropriate to combine the two subscales to form a total MSIS score.</p> <p>Conclusion</p> <p>In this first study to use Rasch analysis to fully assess the psychometric properties of the MSIS-29 support was found for the two subscales but not for the use of the total scale. Further use of Rasch analysis on the MSIS-29 in larger and broader samples is recommended to confirm these findings.</p>
first_indexed 2024-12-21T07:27:27Z
format Article
id doaj.art-82c7b7cd813f4abdb058ea04614cae1e
institution Directory Open Access Journal
issn 1477-7525
language English
last_indexed 2024-12-21T07:27:27Z
publishDate 2009-06-01
publisher BMC
record_format Article
series Health and Quality of Life Outcomes
spelling doaj.art-82c7b7cd813f4abdb058ea04614cae1e2022-12-21T19:11:38ZengBMCHealth and Quality of Life Outcomes1477-75252009-06-01715810.1186/1477-7525-7-58Rasch analysis of the Multiple Sclerosis Impact Scale (MSIS-29)Misajon RoseKhan FaryRamp MelinaPallant Julie F<p>Abstract</p> <p>Background</p> <p>Multiple Sclerosis (MS) is a degenerative neurological disease that causes impairments, including spasticity, pain, fatigue, and bladder dysfunction, which negatively impact on quality of life. The Multiple Sclerosis Impact Scale (MSIS-29) is a disease-specific health-related quality of life (HRQoL) instrument, developed using the patient's perspective on disease impact. It consists of two subscales assessing the physical (MSIS-29-PHYS) and psychological (MSIS-29-PSYCH) impact of MS. Although previous studies have found support for the psychometric properties of the MSIS-29 using traditional methods of scale evaluation, the scale has not been subjected to a detailed Rasch analysis. Therefore, the objective of this study was to use Rasch analysis to assess the internal validity of the scale, and its response format, item fit, targeting, internal consistency and dimensionality.</p> <p>Methods</p> <p>Ninety-two persons with definite MS residing in the community were recruited from a tertiary hospital database. Patients completed the MSIS-29 as part of a larger study. Rasch analysis was undertaken to assess the psychometric properties of the MSIS-29.</p> <p>Results</p> <p>Rasch analysis showed overall support for the psychometric properties of the two MSIS-29 subscales, however it was necessary to reduce the response format of the MSIS-29-PHYS to a 3-point response scale. Both subscales were unidimensional, had good internal consistency, and were free from item bias for sex and age. Dimensionality testing indicated it was not appropriate to combine the two subscales to form a total MSIS score.</p> <p>Conclusion</p> <p>In this first study to use Rasch analysis to fully assess the psychometric properties of the MSIS-29 support was found for the two subscales but not for the use of the total scale. Further use of Rasch analysis on the MSIS-29 in larger and broader samples is recommended to confirm these findings.</p>http://www.hqlo.com/content/7/1/58
spellingShingle Misajon Rose
Khan Fary
Ramp Melina
Pallant Julie F
Rasch analysis of the Multiple Sclerosis Impact Scale (MSIS-29)
Health and Quality of Life Outcomes
title Rasch analysis of the Multiple Sclerosis Impact Scale (MSIS-29)
title_full Rasch analysis of the Multiple Sclerosis Impact Scale (MSIS-29)
title_fullStr Rasch analysis of the Multiple Sclerosis Impact Scale (MSIS-29)
title_full_unstemmed Rasch analysis of the Multiple Sclerosis Impact Scale (MSIS-29)
title_short Rasch analysis of the Multiple Sclerosis Impact Scale (MSIS-29)
title_sort rasch analysis of the multiple sclerosis impact scale msis 29
url http://www.hqlo.com/content/7/1/58
work_keys_str_mv AT misajonrose raschanalysisofthemultiplesclerosisimpactscalemsis29
AT khanfary raschanalysisofthemultiplesclerosisimpactscalemsis29
AT rampmelina raschanalysisofthemultiplesclerosisimpactscalemsis29
AT pallantjulief raschanalysisofthemultiplesclerosisimpactscalemsis29